IMPACt of an Enhanced Screening Program on the Detection of Non-AIDS NEOplasms in HIV Patients

Conditions:   HIV/AIDS;   Cancer Interventions:   Diagnostic Test: Digital rectal exam and / or anal cytology (day 1 and after 36 months);   Diagnostic Test: Semestral digital rectal exam and / or anal cytology if abnormal → ANOSCOPY with biopsy;   Diagnostic Test: Cervical cytology and cervical sample for HPV detection (day 1 and after 36 months);   Diagnostic Test: Semestral cervical cytology and cervical sample for HPV detection;   Diagnostic Test: Appointment for mammography (day 1 and after 36 months);   Diagnostic Test: Annual appointment for mammography;   Diagnostic Test: Semestral appointment for liver ultrasound;   Diag nostic Test: Semestral blood collection for alpha-fetoprotein and others hepatic biomarkers determination;   Diagnostic Test: Fecal occult blood test (day 1 and after 36 months);   Diagnostic Test: Annual fecal occult blood test;   Diagnostic Test: Digital rectal exam and PSA determination (day 1 and after 36 months);   Diagnostic Test: Annual digital rectal exam and PSA determination;   Diagnostic Test: Annual appointment for low dose computed tomography for lung screening;   Diagnostic Test: Annual general inspection for skin lesions suggestive of malignancy Sponsors:   Felix Gutierrez;   Instituto de Salud Carlos III (Funding reference PI18/01861);   Hospital General Universitario Reina Sofía de Murcia;   Hospital Universitario Reina Sofia de Cordoba;   Hospital General Universitario de Alicante;   Hospital...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials